| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2400232 | 重组抗HER3人源化单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2024-04-16 | Shanghai Institute of Biological Products Co Ltd | view | ||||
| CXSL1900077 | 重组抗HER3人源化单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2019-07-29 | 上海生物制品研究所有限责任公司 | Shanghai Institute of Biological Products Co Ltd | In Review | 2019-07-25 | view |